After a blockbuster year, Nvidia's meteoric growth may start to slow down in 2025. Veteran trader Stephen 'Sarge' Guilfoyle joined TheStreet to discuss why he's cautious on Nvidia ( NVDA) going into ...

Based on stock price targets, the most bullish analyst on Palantir’s stock could be considered by some to actually be bearish.

Investors might want to bet on Allogene Therapeutics (ALLO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings ...